Why is Hemo Organic falling/rising?

As of 07-Jul, Hemo Organic Ltd's stock price is currently at 9.60, reflecting a decrease of 0.5, or 4.95%. The stock has been underperforming significantly, with a performance today that is 5.65% lower than its sector. It has experienced a consecutive decline over the last three days, resulting in a total drop of 10.2% in the past week. The stock is trading below all key moving averages, indicating a bearish trend. Additionally, there has been a notable decline in investor participation, with delivery volume falling by 28.06% against the five-day average. The company has a negative book value and is considered to have weak long-term fundamental strength, compounded by high debt levels and a negative EBITDA, which further contributes to its recent price decline.
In the broader market context, Hemo Organic's short-term performance has been significantly worse than the benchmark, with a 10.2% drop in the last week compared to a mere 0.2% decline in the Sensex. Over the past year, the stock has generated a return of -19.67%, consistently underperforming against the BSE500 in each of the last three annual periods. While the company reported positive results in March 2025, including the highest quarterly profits, these have not translated into improved stock performance, highlighting a disconnect between short-term financial results and long-term investor confidence.